R G Finch
Overview
Explore the profile of R G Finch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Finch R, Blasi F, Verheij T, Goossens H, Coenen S, Loens K, et al.
Clin Microbiol Infect
. 2012 Jun;
18(9):E308-13.
PMID: 22731501
Antimicrobial resistance is a serious threat and compromises the management of infectious disease. This has particular significance in relation to infections of the respiratory tract, which are the lead cause...
2.
Wilcox M, Fraise A, Bradley C, Walker J, Finch R
J Hosp Infect
. 2011 Feb;
77(3):187-8.
PMID: 21277650
A taskforce has now been formed with representatives from the Department of Health's Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), the Hospital Infection Society (HIS), the Department...
3.
Finch R, Eliopoulos G
J Antimicrob Chemother
. 2005 Mar;
55 Suppl 2:ii5-13.
PMID: 15750036
It would be difficult to envision the practice of infectious diseases over the past 20 years without the availability of the glycopeptide antibiotics. The two agents currently in clinical use,...
4.
Thomson B, Finch R
Clin Microbiol Infect
. 2005 Feb;
11(2):86-94.
PMID: 15679481
Hepatitis C virus (HCV) infection is a major public health problem. Up to 3% of the world's population is infected with HCV, and at least 200 000 adults in the...
5.
Ziglam H, Daniels I, Finch R
J Chemother
. 2004 Aug;
16(4):357-61.
PMID: 15332711
It has been shown that some antibiotics can modify cytokine production. We have examined the effect of rifampicin on secretion of interleukin-1beta (IL-1beta), IL-6, IL-10, and tumor necrosis factor alpha...
6.
Finch R
Clin Microbiol Infect
. 2004 Feb;
10 Suppl 2:1-5.
PMID: 14759227
The development and clinical use of antimicrobial agents continue to evolve in line with new science, understanding and needs. While antimicrobial resistance remains an important determinant for drug development and...
7.
Davies G, Finch R
Clin Microbiol Infect
. 2003 Nov;
9(8):858-63.
PMID: 14616708
Objectives: To evaluate the pattern of emergency adult medical admissions during the winter period and the usefulness of sales of over-the-counter cough/cold remedies as a predictor of these. Methods: The...
8.
Ziglam H, Finch R
Clin Microbiol Infect
. 2001 Nov;
7 Suppl 4:53-65.
PMID: 11688535
The glycopeptide antibacterial drugs vancomycin and teicoplanin are widely used in hospitals for therapy of severe or multiresistant Gram-positive infections, notably staphylococcal, enterococcal and rarely pneumococcal. Vancomycin has also been...
9.
10.
Finch R
J Chemother
. 2001 Jun;
12 Suppl 1:5-7.
PMID: 11414382
Ciprofloxacin's strength is in 'below-the-diaphragm' indications. Information about the efficacy of the new fluoroquinolones in this indication is currently limited. Ciprofloxacin is effective in both uncomplicated and complicated urinary tract...